» Articles » PMID: 28698851

Impact of Labile Plasma Iron and Iron Chelation on the Viability of Cultured Mononuclear Cells from Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

Overview
Journal Blood Res
Publisher Springer Nature
Specialty Hematology
Date 2017 Jul 13
PMID 28698851
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Iron Toxicity and Hemopoietic Cell Transplantation: Time to Change the Paradigm.

Pilo F, Angelucci E Mediterr J Hematol Infect Dis. 2019; 11(1):e2019030.

PMID: 31205634 PMC: 6548208. DOI: 10.4084/MJHID.2019.030.

References
1.
Durken M, Agbenu J, Finckh B, Hubner C, Pichlmeier U, Zeller W . Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation. Bone Marrow Transplant. 1995; 15(5):757-62. View

2.
Bradley S, Gosriwitana I, Srichairatanakool S, Hider R, Porter J . Non-transferrin-bound iron induced by myeloablative chemotherapy. Br J Haematol. 1997; 99(2):337-43. DOI: 10.1046/j.1365-2141.1997.4143221.x. View

3.
Evens A, Mehta J, Gordon L . Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant. 2004; 34(7):561-71. DOI: 10.1038/sj.bmt.1704591. View

4.
Majhail N, Lazarus H, Burns L . Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant. 2008; 41(12):997-1003. DOI: 10.1038/bmt.2008.99. View

5.
Jensen P, Heickendorff L, Pedersen B, Jensen F, Christensen T, Boesen A . The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol. 1996; 94(2):288-99. DOI: 10.1046/j.1365-2141.1996.d01-1795.x. View